PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-4297

  1. 1,028 Posts.
    lightbulb Created with Sketch. 315
    It’s at the hail Mary stage of BioPharma.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.